Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02689167
What this trial is testing

Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma

Who this might be right for
Kidney NeoplasmsMetastatic Renal Cell Cancer
Centre Hospitalier Universitaire de Besancon 226
Testing effectiveness (Phase 2)Study completedNCT00006604
What this trial is testing

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 195
Large-scale testing (Phase 3)WithdrawnNCT03016949
What this trial is testing

Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine

Who this might be right for
Poliomyelitis
Fidec Corporation
Testing effectiveness (Phase 2)Study completedNCT00240968
What this trial is testing

H5 Booster After a Two Dose Schedule

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 337
Testing effectiveness (Phase 2)Ended earlyNCT06833190
What this trial is testing

REGN5381 in Adult Participants With Uncontrolled Hypertension

Who this might be right for
Uncontrolled Hypertension
Regeneron Pharmaceuticals 34
Testing effectiveness (Phase 2)Study completedNCT03502668
What this trial is testing

Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS

Who this might be right for
Myelodysplastic Syndromes
Taiho Oncology, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT00239577
What this trial is testing

A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults

Who this might be right for
Dengue
GlaxoSmithKline 86
Large-scale testing (Phase 3)Active Not RecruitingNCT06534892
What this trial is testing

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 10,212
Large-scale testing (Phase 3)Study completedNCT00514514
What this trial is testing

Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 802
Large-scale testing (Phase 3)Ended earlyNCT00478972
What this trial is testing

Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise

Who this might be right for
ObesityDiabetes Mellitus Type 2
Sanofi 321
Testing effectiveness (Phase 2)Study completedNCT01233362
What this trial is testing

Study of Alternative Vaccination Schedule of Oral Cholera Vaccine

Who this might be right for
CholeraDiarrhoeaVibrio Infection
International Vaccine Institute 386
Large-scale testing (Phase 3)Active Not RecruitingNCT05450705
What this trial is testing

V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,500
Early research (Phase 1)Study completedNCT00135005
What this trial is testing

Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 59
Early research (Phase 1)Study completedNCT01123824
What this trial is testing

Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects

Who this might be right for
Healthy
Sanofi 40
Testing effectiveness (Phase 2)Study completedNCT03802123
What this trial is testing

⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors

Who this might be right for
Positron-Emission TomographyMetastatic Solid Tumors
ImaginAb, Inc. 52
Testing effectiveness (Phase 2)Ended earlyNCT00350623
What this trial is testing

Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 210
Testing effectiveness (Phase 2)Study completedNCT00624351
What this trial is testing

Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease

Who this might be right for
Systemic Lupus Erythematosus
UCB Pharma 227
Not applicableActive Not RecruitingNCT02041845
What this trial is testing

Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Norwegian University of Science and Technology 177
Large-scale testing (Phase 3)Study completedNCT02215980
What this trial is testing

STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 210
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890832
What this trial is testing

Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, MCRPC
Jina Pharmaceuticals Inc. 75
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation